Disclosure: Was alerted to this one in 2023 and watched with interest, did not participate in the CR but was happy to purchase on market at $1.40 after CR.
Very happy to top up here today under $1.20 and will continue to soak up what’s available at this level or below.
Big 12-24 months coming up
Looking forward to next report.
Price has been up and down over last 5 years on nothing material IMO pretty much only speculation in hope of a US Rollout.
FDA approval granted & rollout now here, proven management and logistics, contracts signed, reimbursement by US Gov. Not much downside here IMO.
$90Million+ annual market in the US.
Rest of world $27Million (2024)
As the rollout continues over the next 12-24 months I see plenty of upside, fully funded for rollout with revenue increasing dramatically. Plenty of good news to come, unfortunately lung disease imaging is a very stable industry.
Love to hear regular updates & news from holders as I watch the rollout.
- Forums
- ASX - By Stock
- CYC
- CYC - Daily General Banter & US Rollout
CYC
cyclopharm limited
Add to My Watchlist
1.92%
!
$1.02

CYC - Daily General Banter & US Rollout
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
-0.020(1.92%) |
Mkt cap ! $113.3M |
Open | High | Low | Value | Volume |
$1.04 | $1.05 | $1.02 | $220.9K | 213.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9803 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 49222 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9803 | 1.010 |
4 | 34700 | 1.000 |
1 | 30000 | 0.990 |
1 | 10000 | 0.980 |
1 | 1031 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 49222 | 1 |
1.070 | 11252 | 1 |
1.080 | 32047 | 1 |
1.110 | 1980 | 2 |
1.115 | 2150 | 1 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |